MD Newsline
MD Newsline is a health communications company dedicated to equipping healthcare professionals and health advocates with essential medical resources. Our platform offers a comprehensive range of content focused on disease education, clinical trial updates, the latest insights in medical research, patient adherence strategies, and industry best practices.
Through our targeted resources, we aim to empower healthcare providers and advocates to deliver more informed, effective care while advancing the broader field of medical education.
Our mission is to elevate patient outcomes across all populations by equipping healthcare practitioners with vital medical knowledge that empowers, enlightens, and engages. We are dedicated to providing resources that support healthcare professionals in delivering high-quality, informed care that meets the diverse needs of their patients.
Visit MDNewsline.com
Like us on Facebook at facebook.com/mdnewsline.com
Follow u on Instagram & Twitter @MDNewsline
How AI and Machine Learning Are Reshaping Cancer Care – Dr. Ashley Sumrall
Managing Rare Brain Tumors with Dordabipone (ONC201) – Dr. Ashley Sumrall
Just Diagnosed: Matteo R. Valencia's Journey with Alveolar Soft Part Sarcoma
The Power of Multidisciplinary Teams in Breast Cancer Care – Dr. Eleonora Teplinsky
Side Effect Management and Patient Priorities in Breast Cancer Care – Dr. Eleonora Teplinsky
High-Risk Myeloma: Genomic Testing, Treatment Strategy + Patient-Centered Care ft Dr. Martin Kaiser
Bridging Clinical Trials and Real-World Care: Advancing Leukemia Treatment ft. Dr. Mark Litzow
Evolving CML Strategies: Mutation Profiling to Treatment-Free Remission ft. Dr. Andreas Hochhaus
Rethinking MS: Nutrition, Brain Health, and Outcomes ft. Karen Zozack and Dr. Olivia Wills
MS: Early Diagnosis, High-Efficacy Treatment + the Future of Neuroimmunology ft. Dr. Alice Edwards
Redefining Standards in Bladder, Prostate, and Kidney Cancer ft. Dr. Karine Tawagi
The Role of AI and TDXD in Advancing HER2 Positive Breast Cancer Care – Dr. Eleonora Teplinsky
Cost and Access Challenges in Breast Cancer Drug Approval – Dr. Eleonora Teplinsky
Racial Disparities in Breast Cancer Trials and ASCENT 04 Findings – Dr. Eleonora Teplinsky
SERENA-6 Trial and Camizestrant in Breast Cancer Treatment – Dr. Eleonora Teplinsky
New Treatment Options for Pediatric Psoriasis Patients – Dr. Amy Paller
Overcoming Access Gaps in CML and Leukemia Treatment – Dr. Elias Jabbour
Future of Leukemia Treatment: Cure, Equity, and AI Integration – Dr. Elias Jabbour
How New Targeted Therapies Are Changing Frontline AML Treatment – Dr. Elias Jabbour
Can CAR T Therapy Replace Transplant in Adult ALL Treatment? – Dr. Elias Jabbour
When Can CML Patients Safely Stop TKIs? – Dr. Elias Jabbour
Balancing Cost and Care First Line TKI Decisions in CML Treatment – Dr. Elias Jabbour
How Genomic Testing Is Shaping CML Treatment Decisions – Dr. Elias Jabbour
How TKIs Transformed CML From a Deadly Diagnosis to a Chronic Condition – Dr. Elias Jabbour
Advancing CML and Leukemia Care with TKIs, CAR-T, and AI – Dr. Elias Jabbour
How Hypoglycemia & Incidental Scans Reveal Hidden Endocrine Tumors ft. Dr. Kamrun Naher
Lipodystrophy vs. Cushing, CGM Confidence, & Socioeconomic Barriers ft. Dr. Omolara Adeniran
Why New Oral Medications Could Change Pediatric Psoriasis Treatment – Dr. Amy Paller
The Challenges of Clinical Research in Pediatric Psoriasis – Dr. Amy Paller
Dr. Ashley Sumrall on Treating H3K27M-Mutant Diffuse Midline Gliomas